论文部分内容阅读
目的:探讨稽留流产患者术前口服戊酸雌二醇联合米非司酮后行清宫术的效果观察。方法:选取同时期内住院的稽留流产患者共96例,分为研究组50例,对照组46例。入院后完善相关检查,无用药禁忌症,予口服戊酸雌二醇3mg,3次/d,米非司酮50mg,1次/d,共计3d,之后再行无痛清宫术。对照组不口服戊酸雌二醇及米非司酮,完善检查后直接行无痛清宫术。观察两组手术时间,术中出血量,术后因清宫不全行宫腔镜下残留胎物取出术的例数。结果:研究组较对照组手术时间短,术中出血量少,手术后清宫不全的例数少。结论:稽留流产患者术前口服戊酸雌二醇联合米非司酮后行清宫术具有明显的临床治疗效果,有利于缩短手术时间,减少术中出血量,减少术后清宫不全行宫腔镜手术的几率,有利于患者恢复。
Objective: To investigate the effect of uterine curettage after preoperative oral administration of estradiol valerate combined with mifepristone in patients with missed abortion. Methods: A total of 96 patients with aborted abortion during the same period were selected and divided into study group (50 cases) and control group (46 cases). After admission to improve the relevant inspection, no drug contraindications to oral valerate estradiol 3mg, 3 times / d, mifepristone 50mg, 1 / d, a total of 3d, after no pain curettage. The control group did not take oral estradiol valerate and mifepristone, improve the examination directly painless hysterectomy. The operation time, intraoperative blood loss, postoperative residual hysteroscopic removal of hysteroscopic surgery cases were observed. Results: Compared with the control group, the study group had shorter operation time, less intraoperative blood loss and fewer cases of postoperative dysfunction. Conclusion: Preoperative abortion patients with preoperative oral administration of estradiol valerate combined with mifepristone curettage has obvious clinical effect, which will help to shorten the operation time, reduce the amount of intraoperative bleeding and reduce the postoperative hysteroscopic hysteroscopic surgery The chances are good for the patient to recover.